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In neurons, as in a variety of other cell types, the enzyme phosphatidylinositol-3-kinase
(PI3K) is a key intermediate that is common to the signaling pathways of a number of
peripheral metabolic cues, including insulin and leptin, which are well known to regulate
both metabolic and reproductive functions. This review article will explore the possibility
that PI3K is a key integrator of metabolic and neural signals regulating gonadotropin releas-
ing hormone (GnRH)/luteinizing hormone (LH) release and explore the hypothesis that this
enzyme is pivotal in many disorders where gonadotropin release is at risk. Although the
mechanisms mediating the inﬂuence of metabolism and nutrition on fertility are currently
unclear, the strong association between metabolic disorders and infertility is undeniable.
For example, women suffering from anorectic disorders experience amenorrhea as a con-
sequence of malnutrition-induced impairment of LH release, and at the other extreme,
obesity is also commonly co-morbid with menstrual dysfunction and infertility. Impaired
hypothalamic insulin and leptin receptor signaling is thought to be at the core of reproduc-
tive disorders associated with metabolic dysfunction.While low levels of leptin and insulin
characterize states of negative energy balance, prolonged nutrient excess is associated
with insulin and leptin resistance. Metabolic models known to alter GnRH/LH release such
as diabetes, diet-induced obesity, and caloric restriction are also accompanied by impair-
ment of PI3K signaling in insulin and leptin sensitive tissues including the hypothalamus.
However, a clear link between this signaling pathway and the control of GnRH release by
peripheral metabolic cues has not been established. Investigating the role of the signaling
pathways shared by metabolic cues that are critical for a normal reproductive state can help
identify possible targets in the treatment of metabolic and reproductive disorders such as
polycystic ovarian syndrome.
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INTRODUCTION
The achievement of reproductive competence as well as the nor-
mal sustenance of adult reproductive activity is highly affected
by the availability of nutrients. This is particularly evident in
female mammals, where physiological processes such as gestation,
parturition, lactation, and rearing of the young are energetically
demanding. Thus, the hypothalamic pituitary gonadal (HPG) axis
limits fertility when nutrient availability is inadequate to support
these events. Many studies suggest that negative energy balance
inhibits reproduction through the alteration of gonadotropin
releasing hormone (GnRH) secretion in the hypothalamus. GnRH
neurons are often described as the “master regulators” of the HPG
axis meaning that successful reproduction and thus the survival of
the species in mammals depends on the ability of these neurons to
sense changes in the internal and external environment, including
changes in energy status. The intermittent discharge from these
specialized neurons in the hypothalamus is in fact responsible for
the pulsatile secretion of the gonadotropins luteinizing hormone
(LH) and follicle-stimulating hormone (FSH). These in turn act
on the gonads to direct gametogenesis and secretion of steroid
hormones. Within the brain, the actions of gonadal steroids are
then manifested as both feedback regulation of GnRH secretion
and the facilitation of sexual behavior.
The mechanisms by which metabolic information is relayed
to the hypothalamic GnRH network are not entirely clear. How-
ever, various peripheral metabolic signals, such as leptin and
insulin, act on speciﬁc neuronal populations that in turn affect
GnRH neuronal function. This is the case for multiple hypothal-
amic neuropeptide systems such as neuropeptide Y (NPY), prod-
ucts of pro-opiomelanocortin (POMC), and galanin-like peptide
(GALP), among many others (Crown et al., 2007). When these
neuronal populations are not able to appropriately respond to
metabolic cues, for example in states of malnutrition, obesity,
and diabetes, the repercussions are not limited to imbalanced
metabolic homeostasis, but can include reproductive dysfunction.
Therefore, metabolic hormones have a pivotal role in the central
regulationof theHPGaxis.Much less is known,however, about the
intracellular signaling pathways that integrate the actions of meta-
bolic signals to regulate GnRH/LH release and hence reproductive
function. The variety and complexity of signaling networks that
affect cell metabolism and neuronal activity make this a daunting
task. However, peripheral hormones and metabolic cues such as
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leptin and insulin share speciﬁc signal transduction pathways that
in many cases act synergistically or in parallel to affect neuronal
function. Therefore, molecules that serve as central integrators
of metabolism and reproductive function might be identiﬁed by
determining which signaling pathways are shared by peripheral
metabolic cues known to affect both physiological functions.
The PI3K signaling cascade is well known for its role in medi-
ating insulin and leptin effects on cell and tissue metabolism. This
lipid enzyme is activated in classical metabolic tissues such as liver,
pancreas, skeletal muscle, and adipose tissue, where it participates
in the regulation of carbohydrate and lipid homeostasis (Foukas
and Withers, 2010). In addition, central activation of PI3K plays a
key role in the effect of leptin and insulin on food intake and glu-
cose homeostasis (Morton et al., 2005; Xu et al., 2005). The critical
role that PI3K plays in regulation of metabolism does not exclude
the possibility that it also participates in the control of other physi-
ological processes such as reproduction. In fact, the PI3K signaling
cascade is a common pathway activated by hormones and growth
factors that are also critical for the normal function of the HPG
axis, including insulin and leptin. It remains to be determined
whether this signaling pathway integrates the effects of these or
other hormones and growth factors in the regulation of GnRH
release. Furthermore, the brain sites and neuronal populations in
which activation of this enzyme is necessary for the regulation of
energy homeostasis might not be the same as those involved in the
regulation of the HPG axis.
This article reviews the studies supporting the idea that hypo-
thalamic control of GnRH/LHrelease byperipheralmetabolic cues
is indispensable for the normal function of the HPG axis. Then the
hypothesis that PI3K is a key integrator of metabolic and neural
signals regulating GnRH neurosecretion will be explored.
DYSREGULATION OF GnRH/LH RELEASE BY METABOLIC
IMBALANCE
NEGATIVE ENERGY BALANCE
Examples of the effects that a dramatic decrease in caloric intake
has on the reproductive axis can be found in patients suffering
from eating disorders such as anorexia nervosa (AN) and in female
athletes undergoing extreme exercise regimens (Poyastro Pinheiro
et al., 2007; Attia and Roberto, 2009). In these women, hypothal-
amic amenorrhea and menstrual irregularities are associated with
impairments in gonadotropins, speciﬁcally LH release (Attia and
Roberto, 2009). These effects are likely due to decreased amplitude
and/or frequency of hypothalamic pulses of GnRH.
To better understand themechanisms bywhich negative energy
balance disrupts reproductive function, a number of in vivo ani-
mal models have been developed. These include streptozotocin
(STZ)-induced type 1 diabetes (Kovacs et al., 2002, 2003), extreme
exercise (Manning and Bronson, 1989), chemical inhibition of
metabolic pathways such as glucose oxidation (Nagatani et al.,
1996), lipoprivation (Shahab et al., 2006; Sajapitak et al., 2008),
as well as chronic and acute food restriction in adult (Dyer et al.,
1985; Cameron and Nosbisch, 1991), and peripubertal animals
(Bronson, 1986, 1988). The latter model takes advantage of the
phenomenon of “catch up” growth in which stopping growth at a
particular body weight halts reproductive development and subse-
quent reinitiation of ad libitum feeding results in rapid growth and
reproductive development (Bronson, 1986). These negative meta-
bolic challenges can affect the HPG axis at various levels including
decreased gonadotropin secretion, slow follicular development,
and inhibited synthesis of gonadal steroids (Schneider, 2004).
However, it is the inhibition of the GnRH pulse generator, and
hence GnRH release, that is responsible for the dysfunction of the
reproductive axis. For instance, infusing GnRH in a pulsatile man-
ner can yield close to normal onset of puberty in food-restricted
female rats, even in the total absence of body growth (Bronson,
1986). Likewise, pulsatile treatment with GnRH in food-deprived
or food-restricted adult mammals also reinstates HPG normal
function (Rojdmark, 1987; Foster et al., 1989; Cameron and Nos-
bisch, 1991). These studies conﬁrm that positive energy balance
is crucial for normal reproductive function, whether the female
is an adult or peripubertal, and that proper activity of the GnRH
network is essential for this to occur.
Conditions of energy deﬁcit are associated with a drastic
decrease in the levels of peripherally produced metabolic cues
such as insulin and the adipocyte-derived cytokine leptin. The
reduction in the levels of these signals contributes to the decrease
in GnRH/LH activity produced by negative energy balance. For
example, central infusion of leptin or insulin restores the repro-
ductive deﬁcits observed using in vivo models in which energy
balance is severely compromised such as food restriction (Nagatani
et al., 1998) or type 1 diabetes (Kovacs et al., 2002), respectively.
In addition, leptin treatment improves mean LH pulse frequency
andovulationwhen administered toANpatients (Chan andMant-
zoros, 2005). These studies emphasized the importance of leptin
and insulin in the metabolic control of the HPG axis. However, a
decrease in the levels of other peripherally produced signals such
as insulin-like growth factor-1 (IGF-1), glucose, and lipids may
also contribute to the suppression of GnRH activity produced by
negative energy balance.
CHRONIC EXCESS NUTRITION: OBESITY
Fewer studies have examined the effects of a state of excess nutri-
tion on GnRH/LH release and its impact on the rest of the HPG
axis. Diet-induced obesity (DIO) in rodents has been utilized to
mimic the gradual increase in body fat and body weight observed
inobesehumans. Similar tohumans,micewithDIOdisplay fasting
hyperglycemia, hyperinsulinemia, and hyperleptinemia accompa-
nied by insulin and/or leptin resistance (Tortoriello et al., 2004;
Ghanayem et al., 2010). In female mice, DIO causes infertility, the
degree of which depends on the background strain, the duration,
and the percentage of fat in the diet. For example, compared to
other strains such as C57BL/6,DBA/2J female mice show high sus-
ceptibility to high fat diet (HFD)-induced infertility. In these mice,
a diet containing 24% fat is sufﬁcient to signiﬁcantly decrease nat-
ural pregnancy rates and follicular activity (Tortoriello et al., 2004).
Their fertility defect is likely of central origin, because normal ovu-
latory responses and pregnancy rates are restored after exogenous
gonadotropin stimulation (Tortoriello et al., 2004). Addition-
ally, prolonged hyperleptinemia and central leptin resistance are
accompanied by reduced hypothalamic GnRH gene expression
(Tortoriello et al., 2004). However, whether reduction in GnRH
expression caused by DIO in DBA/2J mice results in diminished
hypothalamic GnRH secretion is unknown. In contrast, studies
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using different strains of mice (i.e., mixed CD1/129vJ/57BL6)
have found that elevated LH levels might be the primary mediator
of DIO-induced infertility (Brothers et al., 2010). In these mice,
60% fat content in the diet resulted in decreased fertility, lack of
regular estrous cyclicity, and reduced follicular activity (Brothers
et al., 2010). The elevated LH levels observed in this model of
DIO suggest that obesity affects the ability of steroid hormones to
exert negative feedbackonGnRHsecretion. Interestingly,although
this diet resulted in peripheral insulin resistance, the pituitary
remained responsive to insulin and exhibited a heightened pitu-
itary response to GnRH due to an increase in GnRH receptors
(Brothers et al., 2010). In addition, DIO on this genetic back-
ground resulted in elevated androgen levels, a characteristic of
polycystic ovarian syndrome (PCOS). In this context, it is valid to
point out that rodent models of PCOS, such as female rats exposed
to prenatal androgens, in addition to developing characteristics of
the metabolic syndrome also have elevated androgen and LH lev-
els, suggesting that an acceleration of the GnRH pulse generator
mediates infertility (Demissie et al., 2008; Foecking et al., 2008).
Unfortunately, studies of DIO effects onmale fertility are scarce. In
general,male mice are very resistant to the detrimental effects DIO
on fertility, even though it also results in similar degrees of obe-
sity, insulin resistance, and hyperleptinemia. In order to observe
reduced fertility in males, both a diet with a high fat content (60%)
and a prolonged exposure to it are needed (Ghanayem et al., 2010).
In women, obesity is co-morbid with menstrual dysfunction,
decreased fertility, and an increased risk of miscarriages (Pasquali
et al., 2007). In men, it can result in reduced testosterone (T) levels
and erectile dysfunction (Lebinger, 2007). In the latter, increased
estradiol-17β (E2) levels from peripheral adipose tissue excess can
then lead to secondary hypogonadism through negative feedback
on theHPGaxis (Pitteloud et al.,2005;Kasturi et al.,2008).Obesity
can also exacerbate female reproductive disorders such as PCOS
(Lebinger, 2007; Nestler, 2008). PCOS is the most common cause
of infertility in women; it is characterized by hyperandrogenemia
and elevated LH (Lebinger, 2007; Nestler, 2008). As with states
of negative energy balance, alterations in the levels of peripheral
metabolic cues, such as hyperinsulinemia and hyperleptinemia,
characterize these metabolic disorders and are thought to play a
major role in the central dysregulation of GnRH/LH pulsatility
that is observed in many cases. Speciﬁcally, a decreased sensitivity
of the HPG axis to insulin and leptin actions due to insulin and
leptin resistance is suspected to be a major contributing factor.
ENERGY IMBALANCE AND PUBERTAL DEVELOPMENT
The effects of eating and metabolic disorders on the reproductive
axis are not limited to adults.Nutritional disturbances during early
developmental stages can have adverse consequences on the repro-
ductive axis aswell. For instance,malnutrition and sickness in chil-
dren can cause delayed puberty (Euling et al., 2008). On the other
hand, the prevalence of obesity and other metabolic diseases in
children and adolescents has increased at alarming rates in recent
decades. Several studies suggest that this too represents ametabolic
challenge for normal reproductive development. In girls, obesity
has been associated with precocious puberty (Buyken et al., 2009),
whereas the opposite has been found in boys, with obesity increas-
ing the probability of delayed puberty (Lee et al., 2010). At the
neuroendocrine level, puberty starts when GnRH neurons secrete
GnRH in a pulsatile manner. Although there are no clear data link-
ing obesity with premature activation of gonadotropin secretion
in girls, an increase in adiposity, insulin, and leptin levels during
childhood and adolescence can alter the secretion of other steroid
hormones such as androgens from ovarian and/or adrenal origin
(reviewed in Burt Solorzano and McCartney, 2010). Androgens
can in turn alter the feedback mechanisms that normally restrain
GnRH/LH secretion. This is one of the reasons childhood obesity
has been linked to adult PCOS (Brewer et al., 2010; Burt Solorzano
and McCartney, 2010).
As interest in the effects of obesity on child development has
increased, so have studies investigating the effects of diet on
puberty. In female rodents, states of negative energy balance delay
puberty, whereas a HFD has the opposite effect, advancing puber-
tal onset. Female rats and mice receiving a HFD immediately after
weaning showed advanced timing of vaginal opening (VO) when
compared to littermates exposed to a lean diet (Boukouvalas et al.,
2008; Brill and Moenter, 2009). In mice, the effect of a HFD on
VO is associated with increased insulin levels (Brill and Moenter,
2009). Furthermore, treatment with the insulin sensitizer met-
formin blocked advancement of VO induced by HFD (Brill and
Moenter, 2009). In the same study, treatment with the androgen
receptor antagonist ﬂutamide blocked pubertal acceleration while
delaying VO in the lean diet fed control group, suggesting that
androgens are involved in the pubertal process. It is important
to point out that VO is an external marker of puberty onset that
reﬂects exposure to pubertal sex steroid levels, but it does not
necessarily imply central activation of gonadotropin secretion.
Other parameters, such as day of ﬁrst estrus and measurement
of gonadotropin levels, are needed to further characterize these
models. Nevertheless, it seems that an imbalance in insulin levels,
which is known to stimulate androgen synthesis, contributes to the
“precocious” pubertal onset induced by a HFD. These results also
support a model where obesity alters the hypothalamic sensitivity
to the restraining effects of steroid negative feedback on GnRH
neuronal activity early in development.
These ﬁndings indicate that alterations in the activity of the
GnRHnetworkunderliemanyof thedetrimental effects thatmeta-
bolic imbalances have on theHPGaxis. Thesemetabolic challenges
are also accompanied by profound alterations in the levels and sen-
sitivity to peripheral hormones and metabolic signals, including
IGF-1, E2, leptin, and insulin. These hormones have in common
the capacity to activate the PI3K pathway in various reproductive
tissues including the hypothalamus.
THE PI3K SIGNALING PATHWAY
Based on their sequence homology, similarities in function, and
substrate speciﬁcity, PI3Ks are grouped into three principal cat-
egories: Classes I, II, and III (Vanhaesebroeck et al., 2005). Class
I PI3Ks exist as heterodimers composed of a regulatory/adapter
subunit tightly associated with a catalytic subunit. Class I is fur-
ther divided into Class IA and Class IB. Three isoforms of the
Class IA catalytic subunits p110 have been described, namely
p110α, p110β, and p110δ, whereas three mammalian genes encode
the Class IA adapter subunits p85α, p85β, and p55γ (Vanhae-
sebroeck et al., 2005). Class IA regulatory subunits bind to
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tyrosine-phosphorylated proteins through their SH2 (Src homol-
ogy 2) domains, linking them to tyrosine kinase signaling path-
ways. In contrast, the Class IB regulatory subunits p84 and p101
lack SH2 domains and instead couple theClass IB catalytic subunit
p110γ to G protein-coupled receptors. We will limit our discus-
sion to Class IA PI3Ks, which are the major targets of insulin and
leptin actions.
PI3Ks utilize phosphatidylinositol 4,5-bisphosphate (PIP2)
as the main substrate to generate phosphatidylinositol 3,4,5-
trisphosphate (PIP3), which then acts as a second messenger lipid
to allosterically modify the activity and/or induce the subcellu-
lar relocalization of downstream signaling molecules by binding
to their pleckstrin homology (PH) domains (Cantrell, 2001). For
example, receptor-mediated phosphorylation of speciﬁc tyrosine
residues in proteins such as insulin receptor substrates (IRS), pro-
duce docking sites that bind to the SH2 domains of p85, hence
targeting the catalytic subunit to the membrane (Backer et al.,
1992; Carpenter et al., 1993). Activated PI3K can then affect cel-
lular functions through speciﬁc signaling pathways such as the
serine/threonine protein kinase Akt. Intracellular proteins that are
targets of the Akt pathway include glycogen synthase kinase-3
(GSK3β), members of the forkhead family of transcription fac-
tors, and the mammalian target of rapamycin (mTOR; Cantrell,
2001; Kozma and Thomas, 2002). These enzymes and transcrip-
tion factors regulate intracellular metabolic functions such as the
generation of glucose and protein synthesis (for a review see
Vanhaesebroeck et al., 2005).
Non-receptor tyrosine kinases such as the cytoplasmic Janus
tyrosine kinase family (JAKs) as well as other adapter proteins
like GRB-2 at the plasma membrane can also initiate PI3K sig-
naling in response to insulin, leptin, and growth factors (Cantrell,
2001). Therefore, the potential for activation by a variety of mech-
anisms as well as its cross-talk with other signaling pathways such
as the Ras/MAPK pathway confers upon this lipid kinase the abil-
ity to be involved in a variety of biological functions including
reproduction.
PI3K SIGNALING MOLECULES AND THE CONTROL OF THE
HPG AXIS
Pharmacological and genetic studies have demonstrated a role of
several members of the PI3K signaling pathway in reproductive
function (Table 1). Examples include upstream regulators of PI3K
signaling such as estrogen receptor alpha (ERα), the IGF-1 recep-
tor (IGF-1R), the insulin receptor (IR), and the leptin receptor
(LepR), as well as downstream targets of the Akt branch down-
stream of PI3K, such as mTOR. Moreover, the steroid hormones
E2 and progesterone (P), which are essential for the regulation
of puberty, LH release, and sexual behavior, are known to alter
the expression and/or activity of members of this signaling path-
way such as p85α, IRS-1, and IRS-2. Below is a summary of these
ﬁndings.
ESTROGEN RECEPTOR α
The steroid hormone E2 is essential for the feedback regulation of
gonadotropin release and female reproductive behavior. These E2
effects are dependent on the activation of ERα in speciﬁc neu-
ronal populations of the preoptic area–anterior hypothalamus
(POA–AH) and the mediobasal hypothalamus–median eminence
(MBH–ME, for reviews see (Couse and Korach, 1999; Roepke
et al., 2011)). Traditionally, E2 acts through its receptor to reg-
ulate the transcription of important genes for reproduction, such
as the progesterone receptor. However, E2 is also capable of induc-
ing rapid non-genomic actions. This “non-classical” ERα signal-
ing includes mechanisms in which cytoplasmic or membrane-
associated receptor activation is coupled to stimulation of cyto-
plasmic signaling pathways, including the PI3K signaling cascade
(Acosta-Martinez et al., 2009).
Cross-talk between ERα and PI3K signaling occurs at various
levels. For example, in vitro PI3K signaling induces the phospho-
rylation of discrete residues of the endogenous ER, upregulating
its transcriptional activity and stability (Campbell et al., 2001).
Likewise, E2, presumably acting on membrane ERs, induces PI3K
activity,which results in activation of gene transcription in the tar-
get cell (Pasapera Limon et al., 2003). In vivo, E2 treatment evokes
rapid activation of Akt in the hypothalamus (Burt et al., 2011).
ERα is required for the E2 activation of hypothalamic Akt since
in ERα KO mice acute E2 treatment is no longer able to stimulate
Akt phosphorylation (Burt et al., 2011). There is also biochemi-
cal evidence demonstrating that ERα binds to the PI3K regulatory
subunit p85α in a ligand-dependent manner (Simoncini et al.,
2000;Mendez et al., 2003). The interaction between ERα and p85α
results in the activationofAkt and endothelial nitric oxide synthase
(eNOS; Simoncini et al., 2000).
The PI3K signaling pathway participates in the E2 facilitation of
lordosis behavior, a reﬂexive posture displayed by female rodents
during mating. The PI3K inhibitors wortmannin and LY294002
partially suppressed lordosis when administered during E2 prim-
ing (Etgen and Acosta-Martinez, 2003). Interestingly, when both
wortmannin and the MAPK inhibitor PD98059 are simultane-
ously infused, lordosis behavior is completely abolished (Etgen and
Acosta-Martinez, 2003). Therefore, the complete inhibition of this
E2-dependent behavior requires concurrent suppression of both
central MAPK and PI3K signaling. Future studies should examine
whether central inhibition of PI3K participates in E2-induced LH
release.
INSULIN-LIKE GROWTH FACTOR-1 RECEPTOR
The actions of IGF-1 are mediated through activation of its recep-
tor (IGF-1R), a member of the tyrosine kinase receptor family
that signals through the IRS/PI3K and the MAPK signaling cas-
cades (Nakae et al., 2001). In addition to its prominent role in
the regulation of somatic growth, the IGF-1R signaling path-
way participates in the regulation of GnRH release, the progres-
sion of puberty, adult reproductive function, and sexual behavior
(reviewed in Daftary and Gore, 2005). Although IGF-1 can regu-
late the HPG axis by acting at the pituitary and gonads, it also acts
centrally to stimulate GnRH release and puberty. For example, in
peripubertal rats intracerebroventricular (i.c.v.) infusion of IGF-1
increases plasma LH levels, a response that is blocked by central
immunoneutralization of GnRH (Hiney et al., 1996).
Recent studies suggest that the IGF-1 effect on advancing
pubertal onset is mediated through direct regulation of GnRH
neurons, which are known to co-express IGF-1Rs. Male and
femalemice with the IGF-1R speciﬁcally deleted inGnRHneurons
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Table 1 | Summary of studies on the role of upstream and downstream components of the PI3K signaling pathway in HPG axis function.
Molecule Description Experimental approach Results References
ERα Estrogen hormone
receptor
Global KO Infertility: elevated LH and E2, ovarian
hemorrhage
Couse and Korach (1999),
Mayer et al. (2010)
Binds the PI3K regulatory
subunit p85α
Kisspeptin-cell speciﬁc deletion Advancement of puberty onset in female
mice accompanied by elevated LH, abnormal
ovulatory activity in the adult
IGF-1R Receptor tyrosine kinase GnRH neuron-speciﬁc deletion Delayed pubertal development (VO) with
normal fertility
Divall et al. (2010)
i.c.v. infusion of the IGF-1-R
antagonist JB-1 in E2 +P-primed
ovx rats
Attenuation of lordosis behavior Quesada and Etgen
(2002), Etgen and
Acosta-Martinez (2003)Blockade of hormone-induced LH surge
IR Receptor tyrosine kinase Neuron-speciﬁc deletion Impaired spermatogenesis and ovarian
follicle maturation, reduced LH levels
Bruning et al. (2000)
LepR Class I type cytokine
receptor
Global KO Infertility: delayed/abnormal puberty, low
gonadotropins
Leibel et al. (2001), Ring
and Zeltser (2010)
Hypothalamic deletion Infertility: absence of offspring
IRS-2 Adaptor protein Global KO Infertility: anovulatory ovaries with reduced
number of follicles, reduced pituitary size,
low levels of LH, prolactin, and sex steroids
Burks et al. (2000)
IRS-4 Adaptor protein Global KO Decreased number of litters Fantin et al. (2000)
mTOR Ser/thr kinase i.c.v. infusion of the mTOR
signaling inhibitor, rapamycin in
prepubertal female rats
Delayed VO, decreased LH and E2 levels,
ovarian and uterine atrophy
Roa et al. (2009b)
p85α Class IA PI3K regulatory
subunit
GnRH neuron-speciﬁc deletion Decreased serum LH, T and sperm counts. Acosta-Martinez et al.
(2009)
(GnRH–IGF-1R KO) experienced delayed pubertal development
with normal fertility (Divall et al., 2010). Administration of IGF-1
is not able to advance puberty onset inGnRH–IGF-1RKO females,
suggesting that the re-activation of the GnRH pulse generator at
puberty is triggered by activation of IGF-1Rs in GnRH neurons.
Compared to WT littermates, pre- and peripubertal GnRH–IGF-
1R KO mice have a reduced number of GnRH neurons with
complex dendritic trees and a signiﬁcantly lower proportion of
GnRH neurons with spines. The authors concluded that IGF-
1R regulation of GnRH synaptic structure during the prepubertal
period is critical for the induction of GnRH pulsatility at puberty
onset (Divall et al., 2010).
Finally, central IGF-1Rs regulate adult LH release and sexual
receptivity (lordosis) in female rats. Chronic i.c.v. infusion of the
highly selective IGF-1R antagonist JB-1 suppresses E2-induced
LH release and partially inhibits lordosis behavior (Quesada and
Etgen, 2002; Etgen and Acosta-Martinez, 2003). The effect of JB-1
on LH release is not observed in ovariectomized rats given no hor-
mone replacement, suggesting that JB-1 acts primarily to suppress
E2-positive feedback (Quesada and Etgen, 2002). Participation of
IGF-1R signaling in E2-induced synaptic remodeling in the hypo-
thalamic arcuate nucleus (ARC), which is dependent on IGF-1R
activity,mayunderlie IGF-1 stimulatory effects on adult LH release
(Fernandez-Galaz et al., 1999).
INSULIN AND LEPTIN RECEPTORS
Transgenic mouse models and in vivo pharmacological studies
have demonstrated that leptin and insulin receptor signaling in
the brain has a major role in the regulation of the HPG axis. When
male and female db/db mice (which have a global LepR muta-
tion) are subjected to a neuron-speciﬁc LepR knock in, obesity,
diabetes, and infertility are reversed (de Luca et al., 2005). The
brain-speciﬁc deletion of the IR results in obesity and hypothal-
amic hypogonadism (Bruning et al., 2000). However, the brain
region(s) and the phenotype of the neurons that are responsi-
ble for leptin and insulin actions on the reproductive axis are
largely unknown. GnRH neurons are unlikely to be direct tar-
gets for leptin or insulin in rodents. Recent studies show that
the GnRH neuron-speciﬁc deletion of either receptor does not
affect puberty or adult HPG axis function (Quennell et al., 2009;
Divall et al., 2010). Therefore, it is likely that these and other
peripheral metabolic cues inform the HPG axis about energetic
status via a complex network of neurons and interneurons, many
of which are functionally connected to GnRH neurons. In this
regard, the combined deletion of IR and LepR in POMC neurons
results in high T levels, ovarian abnormalities, and reduced fer-
tility (Hill et al., 2010). Interestingly, a reproductive phenotype
is not observed in single deletions of either receptor in POMC
neurons (Balthasar et al., 2004; Konner et al., 2007). In view of
the fact that deletion of the LepR or the IR in all neurons results
in low LH levels, it is likely that the role each receptor has in the
control of the HPG axis depends on the phenotype of the neu-
rons in which it is expressed, as well as environmental and genetic
circumstances.
Insulin and leptin converge on PI3K signaling to centrally reg-
ulate feeding and glucose homeostasis (Niswender et al., 2003).
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Their receptors activate PI3K through the phosphorylation of
tyrosine residues on IRS proteins (Foukas and Withers, 2010). In
the case of the LepR this is accomplished through the JAK/signal
transducer and activator of transcription (STAT3) signaling path-
way, whereas IR autophosphorylation on tyrosine residues pro-
vides docking sites for the IRS (Niswender et al., 2003; Foukas
and Withers, 2010). Intracerebroventricular infusion of PI3K
inhibitors blocks the ability of insulin and leptin to inhibit food
intake (Niswender et al., 2003; Morrison et al., 2005). Leptin and
insulin reduce appetite by decreasing the production of potent
orexigenic neuropeptides such as NPY and agouti related peptide
(AgRP),while increasing the expressionof anorexigenicneuropep-
tides such as POMC (Munzberg et al., 2003; Morrison et al.,
2005). Leptin regulation of NPY/AgRP transcription depends on
PI3K signaling, while that of POMC requires activation of the
JAK/STAT3 pathway (Munzberg et al., 2003;Morrison et al., 2005).
PI3K is also involved in insulin and leptin effects on themembrane
potential and ﬁring rates of these ARC neurons (Plum et al., 2006;
Hill et al., 2008; Al-Qassab et al., 2009). Since both leptin and
insulin stimulate LH release, it is tempting to speculate that PI3K
also serves as an integrator for the effects that these hormones have
on the HPG axis.
As discussed previously, leptin and insulin resistance are
thought to mediate, in part, the detrimental effects of obesity on
theHPGaxis.Central leptin resistance is associatedwith adefective
PI3Kpathway in the hypothalamus. For example, the ability of lep-
tin to induce hypothalamic PI3K activity is impaired in mice fed a
HFD (Metlakunta et al., 2008). These animals are hyperleptine-
mic, hyperinsulinemic, and have impaired glucose and insulin
tolerance. Moreover, leptin fails to induce PI3K activity as early
as 4 weeks after a HFD, whereas at this age, phosphorylation of
STAT3 by leptin is not impaired (Metlakunta et al., 2008). A recent
study using mouse lines with reduced IR expression in the brain
and the ovary show that insulin resistant and hyperinsulinemic
mice have impaired HPG axis activity (Nandi et al., 2010). This
includes altered duration of estrous cycles, aberrant distribution,
and morphology of ovarian follicles, and a decrease in pregnancy
outcomes. These effects were observed in the absence of body
weight gain and hyperglycemia, suggesting that abnormal insulin
signaling, independent of adipose tissue mass or hyperglycemia,
can affect HPG axis function. Even though these studies demon-
strate the importance of IR and LepR signaling for normal HPG
axis activity, it is impossible to assess whether defects in IR and
LepR signaling in the brain vs. other reproductive tissues, such
as the ovary and the pituitary, are responsible for the detrimental
effects on the HPG axis. This remains an important question since
HFD-induced obesity promotes insulin resistance in the ovary of
rats and increases pituitary sensitivity to GnRH in mice (Akamine
et al., 2010; Brothers et al., 2010). One way to address the question
of whether impaired PI3K signaling in the brain is responsible
for the effects of obesity on the HPG axis would be to investi-
gate whether an increase in PI3K activity could rescue or lower
LH levels in such models. Possible approaches include the use
of brain region-speciﬁc adenoviral expression of a constitutively
active mutant of PI3K to activate downstream targets such as Akt.
This approach was successfully used to demonstrate that hypo-
thalamic PI3K signaling mediates the effects of insulin treatment
on glucose levels in rats with STZ-induced diabetes (Gelling et al.,
2006).
INSULIN RECEPTOR SUBSTRATES
The IRS family of proteins consists of four members named IRS-
1, -2, -3, and -4 (White, 1998). Upon insulin or IGF-1 receptor
activation, IRS proteins undergo rapid tyrosine phosphoryla-
tion, allowing them to recruit and activate PI3K (White, 1998,
2002). Global ablation studies have revealed a role for IRS-2
and IRS-4 in the integration of metabolism and reproduction.
For example, IRS-2-null female mice are infertile, with deﬁcits
at multiple levels of the reproductive axis, including anovula-
tory ovaries with reduced number of follicles, reduced pituitary
size, as well as very low levels of LH, prolactin, and sex steroids
(Burks et al., 2000). The infertility caused by the deletion of
IRS-2 is not a consequence of abnormal glucose homeostasis as
these females were euglycaemic and only mildly insulin resis-
tant. However, IRS-2-null females exhibit increased food intake,
mild obesity, and have defective leptin-stimulated hypothalamic
STAT3 phosphorylation, suggesting that IRS-2 may integrate the
actions of both insulin and leptin on metabolism and repro-
duction. IRS-4-null mice also exhibit defects in reproduction,
although these are not as severe as those for IRS-2. Compared
to wild type breeders, the number of litters produced by IRS-
4-null breeding pairs is signiﬁcantly lower (Fantin et al., 2000).
Because a reduced frequency of total litters was not observed upon
mating the IRS-4-null males with heterozygous females, IRS-4-
null females are suspected to be responsible for the decrease in
fertility.
Finally, the steroid hormones, E2 and P, regulate the expression
and/or phosphorylation levels of speciﬁc IRS proteins. For exam-
ple, in vitro, P induces IRS-2 gene expression in a progesterone
receptor-dependent manner (Vassen et al., 1999). E2, through acti-
vation of ERα, stimulates tyrosine phosphorylation and nuclear
translocation of IRS-1 in vitro and in the uterus (Richards et al.,
1996; Panno et al., 2006). The effects that growth factors such as
IGF-1 have on gonadotropin release and sexual maturation are
modulated and even dependent on sex steroid hormones such as
E2 (Quesada and Etgen, 2002; Etgen and Acosta-Martinez, 2003;
Daftary and Gore, 2005). Therefore, regulation of IRS proteins
may be a mechanism by which steroid hormones modulate tyro-
sine kinase receptor effects on the HPG axis. Future studies should
examine the effect of steroid hormones on IRS proteins in the
hypothalamus.
THE MAMMALIAN TARGET OF RAPAMYCIN
Mammalian target of rapamycin is activated under nutrient-rich
conditions,whereas its kinase activity is attenuatedwhen nutrients
(amino acids, glucose, and oxygen) are depleted (Howell andMan-
ning, 2011). mTOR exists in two forms of multiprotein complexes:
one that contains raptor protein (mTORC1) and another that con-
tains the protein rictor (mTORC2; Howell and Manning, 2011).
The tuberous sclerosis complex of proteins, TSC1 and TSC2, nor-
mally blocks mTORC1 activation by a variety of signals (Howell
and Manning, 2011). In response to insulin, IGF-1, and other
growth factors, PI3K signaling activates mTORC1, at least in part
throughAkt-mediated phosphorylation of TSC1 and TSC2 (Inoki
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et al., 2002; Manning et al., 2002). Recent studies have linked cen-
tral mTORC1 to the control of puberty onset and gonadotropin
secretion. In pubertal female rats, acute activation of mTOR by
l-leucine stimulates LH secretion and partially rescues the sup-
pression of LH caused by chronic food restriction (Roa et al.,
2009b). Conversely, chronic i.c.v. infusion of rapamycin, a potent
mTORC1 inhibitor, delayed VO, decreased LH and E2 levels, and
produced ovarian and uterine atrophy (Roa et al., 2009b). Central
inhibition of mTOR also abolished the positive effects of leptin
on puberty onset in food-restricted animals (Roa et al., 2009b).
Therefore, mTOR signaling in the brain participates in the con-
trol of puberty onset and gonadotropin secretion. Furthermore, its
activation may be relevant in the suppression of GnRH/LH release
and puberty caused by negative energy balance.
The suppressive effects of mTOR on puberty and gonadotropin
secretion in rats were also accompanied by decreased expression
of kisspeptin mRNA levels in the ARC, linking this neuropeptide
system to the regulation of the HPG axis by nutrients (Roa et al.,
2009b). Kisspeptin is a potent stimulator of LH secretion and
is critical for the initiation and maintenance of adult reproduc-
tion (Castellano et al., 2009). Because a state of positive energy
balance is needed for the normal timing and development of
the reproductive axis, mTOR’s role in pubertal onset and LH
secretion correlates well with its known activation by positive
energy status. As described earlier, IGF-1 is a potent stimulator
of the PI3K/Akt pathway, and central activation of IGF-1 recep-
tors stimulates LH release and accelerates the onset of puberty
in rodents (Daftary and Gore, 2005). IGF-1 also up-regulates
hypothalamic kisspeptin gene expression through the activation
of Akt (Hiney et al., 2010). Therefore, it is possible that an IGF-
1R/PI3K/Akt/mTOR/Kisspeptin pathway plays a role in pubertal
onset and GnRH/LH secretion.
NEUROPEPTIDE SYSTEMS THAT CONVEY ENERGY BALANCE
INFORMATION TO THE GnRH NETWORK
A number of neuropeptide systems have been identiﬁed as pos-
sible mediators of metabolic signaling to the GnRH network.
These include but are not limited to GALP, NPY, and products
of POMC (e.g., alpha-melanocyte stimulating hormone, α-MSH)
in the ARC (Crown et al., 2007), orexin neurons in the lateral
hypothalamic area (LHA; Kohsaka et al., 2001; Small et al., 2003),
melanin-concentrating neurons (MCH) in the LHA and zona
incerta (Chiocchio et al., 2001; Williamson-Hughes et al., 2005;
Murray et al., 2006),nesfatin-1 in the LHA,paraventricular (PVN),
and supraoptic (SON) nuclei (Garcia-Galiano et al., 2010), and
kisspeptin neurons in the anteroventral periventricular nucleus
(AVPV) and the ARC (Castellano et al., 2009). With the exception
of kisspeptin, these neuropeptides serve a dual role, being impor-
tant players for both the central control of feeding and energy
homeostasis and of gonadotropin secretion. Importantly, many
of the neurons that synthesize these neuropeptides co-express
insulin and/or the leptin receptors, and their expression is reg-
ulated by metabolic hormones as well as by sex steroids. This is
important because conditions of negative energy balance affect
the gene and protein expression of these neuropeptides in a brain
region-speciﬁc fashion. This could explain why the ability of these
neuropeptides to either stimulate or suppress LH secretion in the
normal female depends on the hormonal milieu (i.e., presence of
estrogens), developmental stage (i.e., prepubertal vs. adult), and
energetic condition (i.e., fasted vs. normally fed; Table 2).
Each of these neuropeptide systems represents a functional
neuroanatomical pathway that can send projections to areas con-
taining GnRH neurons, in many cases directly inﬂuencing their
activity. A review of the effects that each of these neuropeptides
has on the reproductive axis is beyond the scope of this article.
Instead, the kisspeptin system will be used to illustrate mecha-
nisms by which the indirect regulation of GnRH neuronal activity
by metabolic signals occurs (Figure 1).
KISSPEPTIN: LINKING METABOLIC SIGNALS TO THE CONTROL OF GnRH
NEURONAL FUNCTION
As introduced earlier, kisspeptin and its receptor, the G protein-
coupled receptor GPR-54, have a pivotal role in the regulation
of the HPG axis in mammals (for review see Roa et al., 2009a;
Roseweir and Millar, 2009). Kisspeptin neurons have been pro-
posed to represent a link between systemic metabolic signals such
as leptin and central maintenance of reproductive function. For
example, in rodents, the detrimental effects that negative energy
balance has on the maintenance or the development of the female
reproductive axis is completely rescued by central kisspeptin ther-
apy. The models studied to date include chronic subnutrition of
adult rats (Clarkson et al., 2008),peripubertal female rats subjected
to food restriction (Castellano et al., 2005; Clarkson et al., 2008),
and STZ-induced diabetes in male and female rats (Castellano
et al., 2006a, 2009). In addition to their suppressive effects on LH
release and gonadal function, these states of negative energy bal-
ance are accompanied by suppression of hypothalamic kisspeptin
mRNA levels (Castellano et al., 2006a, 2009; Kalamatianos et al.,
2008). In some cases, i.c.v. infusion of leptin can rescue both
kisspeptin expression and gonadotropin levels (Castellano et al.,
2006a).
Models of obesity accompanied by leptin resistance also result
in suppression of hypothalamic kisspeptin mRNA (Foukas et al.,
2006; Quennell et al., 2011). Compared to WT mice, ob/ob mice
have a signiﬁcantly reduced kisspeptin mRNA level, and lep-
tin administration increases the levels of kisspeptin mRNA in
these mice (Foukas et al., 2006). Almost half of cells expressing
kisspeptin mRNA in the ARC nucleus express the LepR, imply-
ing that kisspeptin neurons are direct targets of leptin (Foukas
et al., 2006). However, the kisspeptin cell-speciﬁc deletion of the
LepR does not affect puberty or fertility in female mice, suggest-
ing that a leptin-kisspeptin signaling pathway is not essential for
normal HPG activity (Donato et al., 2011). On the other hand,
previous studies using metabolic challenges, such as undernutri-
tion and DIO, suggest that this pathway is more relevant under
such metabolic challenges.
Electrophysiological studies have recently shown that the abil-
ity of kisspeptin to stimulateGnRHneuronal activity ismodulated
by neuropeptide systems involved in the regulation of feeding
and energy balance. This is the case for the orexigenic neuropep-
tide MCH. MCH ﬁber projections are in close apposition with a
large number of GnRH cell bodies throughout the POA–AH of
the rat (Williamson-Hughes et al., 2005). In addition, more than
50% of GnRH neurons co-expressed the MCH receptor, MCHR1
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Table 2 | Examples of hypothalamic neuropeptide regulation of LH release.
Neuro-
peptide
Origin
of cell
bodies
Expression of
receptors
in GnRH
neurons
Metabolic
regulation of
neuropeptide
gene
expression
Effect of
neuropeptide
treatment on
LH release
in vivo
Infusion
site
Species and hormone
treatment
References
AgRP ARC ? Food
restriction ↑
Stimulatory 3V Rat: intact male Stanley et al. (1999), Vulliemoz
et al. (2005)Inhibitory 3V Monkey: OVX
NPY ARC NPYY5 Food
restriction↑
Inhibitory 3V Rat: OVX McDonald et al. (1989), Kaynard
et al. (1990), Malven et al. (1992),
Leupen et al. (1997) Leupen and
Levine (1999), Advis et al. (2003),
Tortoriello et al. (2004), Morrison
et al. (2005)
Inhibitory 3V Sheep: OVX
NPYY2 HFD ↑ Stimulatory ME Sheep: intact
Insulin ↓ Stimulatory iv. Rat: at proestrus, OVX+E2 +P
Leptin ↓ Inhibitory 3V Monkey: OVX+ vehicle,
OVX+E2
POMC α-
MSH
ARC MC4R Fasting ↑ Inhibitory ME,
mPOA
Rat: OVX and ADX, E2 Gonzalez et al. (1997)
Rat: OVX and ADX, E2 +P
GALP ARC Receptor
unknown
Fasting ↓ Stimulatory ICV Mice: intact male Jureus et al. (2000), Takatsu et al.
(2001), Krasnow et al. (2003),
Kauffman et al. (2005), Castel-
lano et al. (2006b),Takenoya et al.
(2006), Rich et al. (2007)
STZ–
diabetes ↓
Stimulatory ICV Rat: adult and pubertal male
No effect ICV Rat: adult and pubertal female
Leptin ↑ Stimulatory ICV Female mice: OVX, E2 +P
Stimulatory ICV STZ–diabetic male rat
Insulin ↑ Stimulatory LV Castrated male monkey
Orexin A LHA OR-1 Fasting ↓ Stimulatory ICV Rat: fasted, OVX, E2 +P Mondal et al. (1999), Tamura
et al. (1999), Lopez et al. (2000),
Kohsaka et al. (2001), Bertile et al.
(2003), Small et al. (2003), Gall-
mann et al. (2006)
Stimulatory rPOA Rat: OVX, E
Leptin ↑ Inhibitory ICV, 3V Rat: OVX
Inhibitory mPOA Rat: OVX
Inhibitory mPOA,
ARC/ME
Rat: OVX, E2 +P
MCH LHA,
ZI
MCH1 Fasting ↓ Inhibitory 3V Rat: OVX+E2 Gonzalez et al. (1997),Tsukamura
et al. (2000), Chiocchio et al.
(2001), Williamson-Hughes et al.
(2005), Murray et al. (2006)
Leptin ↓ Stimulatory mPOA,
ME
Rat: OVX+ADX+E2
Nesfatin-
1
LHA,
PVN,
SON
Receptor
unknown
Fasting ↓ Stimulatory ICV Pubertal female rats Garcia-Galiano et al. (2010)
Stimulatory ICV Fasted pubertal female rats
No effect ICV Adult female rats
Kisspeptin ARC,
AVPV
GPR54 Fasting ↓ Stimulatory LV Rat: intact male Irwig et al. (2004), Navarro et al.
(2004), Castellano et al. (2005),
Castellano et al. (2006a), Foukas
et al. (2006), Clarkson et al.
(2008), Kalamatianos et al. (2008),
Castellano et al. (2009), Quennell
et al. (2011)
HFD ↓ Stimulatory ICV Rat: fasted female
Stimulatory ICV Rat: STZ–diabetic intact male
and ORX male
STZ–
diabetes ↓
Stimulatory ICV Rat: STZ–diabetic female,
intact, and OVX
Stimulatory ICV Rat: food restricted adult and
pubertal female
Leptin ↑ Stimulatory ICV Rat: adult and pubertal female
(Williamson-Hughes et al., 2005). Using whole-cell patch clamp
recordings in brain slices from established lines of GFP mice,
MCH was shown to strongly inhibit kisspeptin-activated GnRH
neurons but not kisspeptin-insensitive GnRH neurons (Wu et al.,
2009). These effects are mediated via a direct postsynaptic mech-
anism. Therefore, the MCH neuropeptide system may have a role
in conveying information about energy balance to the HPG axis
by modulating the activity of kisspeptin-sensitive GnRH neurons.
Kisspeptin can also interact with other appetite-regulating
neuropeptide systems, such as POMC and NPY neurons in the
ARC. Many kisspeptin-immunoreactive axonal boutons termi-
nate on or near POMC neurons (Fu and van den Pol, 2010).
Moreover, kisspeptin was found to potently and directly excite
POMCneurons (Fu and van den Pol, 2010). In contrast, kisspeptin
inhibits NPY neurons through a presynaptic mechanism based
on enhancing GABA-mediated inhibitory synaptic tone (Fu and
van den Pol, 2010). Since both POMC and NPY are known
regulators of GnRH release, the ability of kisspeptin to regu-
late their neuronal function provides an additional mechanism
by which metabolic information is conveyed to the HPG axis,
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FIGURE 1 | Neuropeptide neurons such as kisspeptin
could serve as intermediaries for peripheral metabolic cues
to communicate changes in energy status to the GnRH
network. In addition, metabolic signals could be “sensed” by interneurons
that in turn communicate with GnRH neurons to regulate their activity.
Several upstream regulators of PI3K signaling such as the LepR, IR, IGF-1R,
and ERα, are critical for the normal initiation and maintenance of reproductive
function in mammals. In this model, PI3K serves as an integrator of E2, leptin,
insulin, and IGF-1 indirect effects on GnRH neuronal function and hence on
the HPG axis.
i.e., neuropeptides serving as a relay station downstream of
kisspeptin.
In summary, the ability of kisspeptin to stimulate GnRH release
can be directly regulated by peripheral metabolic signals such as
leptin, or by other neuropeptide systems known to regulate GnRH
release (Figure 1). Leptin and insulin directly regulate the gene
expression and/or neuronal activity of many of these appetite-
regulating neuropeptides, such as POMC and NPY. PI3K signaling
plays a key role in the actions of both metabolic cues on these neu-
rons. However, additional challenges include how to differentiate
between PI3Kmetabolic and reproductive effects and how to iden-
tify in which neuronal population PI3K signaling acts to affect
HPG axis activity. The cre/loxP system has offered a wealth of
information about the phenotype of the neurons in which insulin
and leptin receptors act to regulate metabolism and in some cases
reproduction. In the case of PI3K, this has entailed the cell-speciﬁc
ablation of its catalytic (p110) or regulatory (p85) subunits.
TARGETING CLASS IA PI3K REGULATORY AND CATALYTIC
SUBUNITS IN HYPOTHALAMIC NEURONS
The cell-speciﬁc deletion of members of the class I PI3K family
has conﬁrmed the role of this enzyme as a key integrator of the
central effects of insulin and leptin on feeding and metabolic con-
trol. These studies have focused on neuronal populations in the
ARC, such as POMC and AgRP neurons, well known for their
involvement in the central control of feeding and body weight.
The phenotype observed depends on the type of neuron being
targeted (i.e., NPY vs. POMC), as well as the PI3K component
(regulatory vs. catalytic subunit). For example, while mice with
a POMC-speciﬁc deletion of p110α have increased body weight
and adipose tissue, mice with a POMC-speciﬁc deletion of p85α
showed resistance to DIO (Hill et al., 2009). These alterations in
energy homeostasis are often accompanied by the prevention of
insulin- and leptin-stimulated electrophysiological responses (Hill
et al., 2008; Al-Qassab et al., 2009).
No reproductive phenotype has been reported in mice with
POMC- orAgRP-speciﬁc deletion of class IA PI3K catalytic or reg-
ulatory subunits. The same is true in studies of mice with speciﬁc
deletion of the leptin or insulin receptor in POMC- orNPY/AgRP-
expressing neurons. Unfortunately, many of these studies were
carried out in males, whose reproductive axis is more resistant to
the effects of metabolic disturbance. Moreover, the expression of a
reproductive phenotype in these models might depend on the age
of the animal or might be observed only in response to a meta-
bolic challenge. This is the case for female mice with POMC- and
NPY/AgRP-speciﬁc deletion of the LepR,which show reduced fer-
tility with age (Israel and Chua, 2010). Finally, while POMC and
NPY/AgRP neurons are important for the normal regulation of
the HPG axis, and alterations in their gene expression could con-
tribute to the detrimental effects that metabolic disorders have on
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fertility, gene manipulation studies in other neuronal populations
that are essential for pubertal and adult GnRH/LH release are nec-
essary in order to provide information about PI3K’s role in the
control of the HPG axis. Candidate neurons include GnRH and
kisspeptin.
While central regulation of theHPG axis by leptin and insulin is
likely due to actions on interneurons that ultimately controlGnRH
neurosecretion,other signals such as steroid hormones and growth
factors might exert direct regulation of GnRH neurons either dur-
ing development or in the adult. As indicated earlier, many of the
factors that regulateGnRHrelease also have the capacity to activate
cell signaling pathways mediated by PI3K. Examples include E2
through ERα and IGF-1 through IGF-1Rs. To investigate whether
PI3K signaling mediates the direct regulation of GnRH neurons
by these and other factors, we used conditional gene targeting to
ablate the expression of p85α in GnRH neurons.
Surprisingly, the GnRH neuron-speciﬁc deletion of p85α did
not affect the female reproductive axis. Instead, we observed a
male-speciﬁc phenotype consisting of decreased serum LH, T,
and sperm counts (Acosta-Martinez et al., 2009). Furthermore,
the same phenotype was observed when we generated the GnRH
neuron-speciﬁc deletion of p85αon a global p85βKObackground.
Hence, p85β does not substitute for p85α activity toward PI3K
function in GnRH neurons. These ﬁndings suggest that p85α
in GnRH neurons participates in normal GnRH neurosecretory
activity in the male mouse. It remains unknown whether p85α
and PI3K activity in GnRH neurons are required in this regard
during development, in adulthood, or throughout the lifespan.
Although we did not identify the cause of this male-biased
effect, we speculate that PI3K signaling in GnRH neurons par-
ticipates in the organizational effects of E2 during development.
E2, which is aromatized from testicular androgens in the male,
establishes sex differences in synaptic connections and neuronal
morphology that are ultimately responsible for the differentiation
of the male brain from the female brain in mammals (Schwarz
et al., 2008). In the developing hypothalamus, activation of ERs
by E2 promotes dendritic spine formation via rapid, non-genomic
activation of PI3K (Schwarz et al., 2008). Because fetal GnRH
neurons may express ERs (Shariﬁ et al., 2002), it is possible that
this mechanism may be activated in GnRH neurons during the
prenatal/neonatal surges of T production that occur in males. The
subsequent changes in synaptic connectivity might support higher
levels of GnRH neurosecretory activity or increased responsive-
ness to synaptic inputs in adulthood. Such a mechanism might
explain the observation that the GnRH pulse generator operates
at a higher frequency in males than in females of many species,
and that prenatal androgen exposure leads to an acceleration of
GnRHpulsatility in female rodents, sheep, andmonkeys (reviewed
in Foecking et al., 2008).
Besides steroid hormones, PI3K signaling is activated by and
regulates the function of other molecules that affect GnRH neu-
ronal activity through direct mechanisms. This is the case of IGF-
1Rs and ATP-sensitive potassium (KATP) channels, both of which
are expressed inGnRHneurons (Zhang et al., 2007a;Brothers et al.,
2010). While GnRH neuronal expression of IGF-1Rs is impor-
tant for normal pubertal timing, KATP channels confer respon-
siveness to glucose in GnRH neurons and regulate GnRH/LH
release in an E2-dependent manner (Zhang et al., 2007a; Huang
et al., 2008). One can speculate that a reproductive phenotype in
GnRH-speciﬁc p85α KO females might be observed after meta-
bolic challenges such as fasting or DIO. On the other hand, it
is unknown whether p85α’s effects on male GnRH neurons are
mediated through p110-independent or -dependent mechanisms.
Hence, it is possible that a GnRH-speciﬁc deletion of p110 cat-
alytic subunits might alter GnRH neuronal activity resulting in a
reproductive phenotype in females.
Neuronal populations that express ERα and are important for
GnRH/LH release or sexual behavior are also good candidates
to investigate the role of PI3K in the control of reproduction. A
good candidate for this is kisspeptin neurons. The majority of
kisspeptin neurons co-express ERα, with more than 60% in the
AVPV and more than 90% in the ARC (Mayer et al., 2010). In
addition, the kisspeptin cell-speciﬁc deletion of ERα results in
precocious puberty (advanced VO and LH hypersecretion) and
the arrest of subsequent pubertal maturation (Mayer et al., 2010).
Therefore, in addition to relaying metabolic information from
the periphery, PI3K might participate in the direct actions of
E2 on kisspeptin neuronal activity and hence GnRH/LH secre-
tion (Figure 1). Through the use of transgenic mouse models,
experiments in our lab are underway to investigate this possibility.
INFLAMMATION AND PI3K SIGNALING
Obesity is considered to be a chronic inﬂammatory state. With
time, adipose tissue becomes inﬁltrated by macrophages, result-
ing in increased circulating pro-inﬂammatory cytokines such as
transforming growth factor-alpha (TNF-α) and interleukin (IL)-6
(Thaler et al., 2010). The chronic exposure to circulating cytokines
as well as to excess glucose or fatty acids can activate intracellular
inﬂammatory pathways in other cell types and organs includ-
ing the liver, muscle, endothelial cells, and neurons (Thaler and
Schwartz, 2010; Thaler et al., 2010). It has been hypothesized that
hypothalamic inﬂammation resulting from the prolonged con-
sumption of a HFD leads to obesity through the development of
central insulin and leptin resistance (Thaler and Schwartz, 2010).
These are states associated with infertility in both humans and
animal models of DIO. Therefore, chronic immune signals might
also reduce the sensitivity of signaling pathways important for the
central control of the HPG axis.
In humans, a reproductive disorder associated with a state of
chronic low-grade inﬂammation (LGI) is PCOS (Repaci et al.,
2011). Markers of LGI in PCOS patients include elevated TNF-α
(Gonzalez et al., 1999), IL-18 (Escobar-Morreale et al., 2004), IL-
6 (Repaci et al., 2011), and C-reactive protein (CRP; Kelly et al.,
2001; Benson et al., 2008). Many of these inﬂammatory signals
are associated with insulin resistance and high circulating insulin
levels. Insulin resistance, although not part of the diagnostic cri-
teria, is present in a large percentage of women diagnosed with
PCOS, regardless of obesity (Repaci et al., 2011). It has been spec-
ulated that LGI might be the link between hyperandrogenism,
insulin resistance, and the long-term consequences of PCOS. For
example, TNF-α is a known inducer of insulin resistance, presum-
ably through its ability to interfere with insulin receptor signaling
(Feinstein et al., 1993; Uysal et al., 1997). While the focus of these
studies has been on peripheral insulin-responsive organs such as
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muscles and adipose tissue, the effects that long-term TNF-α levels
might have on insulin receptor signaling in reproductive organs
has not yet been investigated. This is of importance since both
TNF-α and insulin are known to modulate ovarian steroid pro-
duction as well as induce cell proliferation in interstitial theca cells
in vitro (Roby and Terranova, 1990; Spaczynski et al., 1999). Inter-
estingly, the ability of insulin to stimulate androgen synthesis by
the ovary is preserved in PCOS patients (Nestler et al., 1998). In
fact, the higher concentration of insulin in women with PCOS is
thought to amplify the effects of LH on androgen production by
theca cells. In in vitro studies using human ovarian theca cells,
insulin augmentation of 17 α-hydroxylase activity, a key enzyme
for androgen biosynthesis, is mediated by PI3K (Munir et al.,
2004). Therefore, ovarian PI3K signaling could potentially con-
tribute to the hyperandrogenemia observed in PCOS. However,
whether or not inﬂammatory signals such as TNF-α modulate
PI3K-mediated androgen production by the ovary is not known.
A role of inﬂammation and insulin resistance in PCOS is also
supported by the marked improvement PCOS patients show after
treatment with insulin sensitizers such as metformin. Long-term
treatment with metformin increases ovulation, improves men-
strual cyclicity, and reduces serumandrogen levels (Lebinger,2007;
Nestler, 2008). Metformin treatment also signiﬁcantly reduces cir-
culating levels of CRP and white blood cells (Morin-Papunen
et al., 2003; Diamanti-Kandarakis et al., 2006; Orio et al., 2007).
The anti-inﬂammatory actions of metformin include the inhi-
bition of IL-1β-induced release of IL-6 and IL-8 in endothelial
cells, human vascular smooth cells, and macrophages (Morin-
Papunen et al., 2003; Diamanti-Kandarakis et al., 2006; Orio et al.,
2007).
The studies cited above focus on the role of inﬂammation
and insulin resistance in peripheral tissues, like the ovaries and
endothelial cells. However, the role that central inﬂammation and
the resultant insulin resistance might play in the pathogenesis of
PCOS, especially on GnRH/LH hypersecretion, is unknown. It is
possible that central actions of metformin contribute to its ben-
eﬁcial effects on HPG axis function, as this drug can cross the
blood–brain barrier. Here, rodentmodels of HFD-induced obesity
and infertility could be used to determine if centrally administered
metformin normalizes LH release.
The mechanisms by which dietary lipids and other nutrients
become more immunogenic by overnutrition are not completely
understood. It is clear, however, that many of the players involved
in the immune response toward disease, by as yet unidentiﬁed
mechanisms, also promote insulin and leptin resistance. In this
context, it is worth mentioning that insulin has anti-inﬂammatory
effects that are independent of its function in regulating glu-
cose homeostasis. In in vivo models of endotoxemia, such as that
induced by acute injection of bacterially derived lipopolysaccha-
ride (LPS), insulin is able to reduce inﬂammation (decreased
plasma levels of IL-6, TNF-α, monocyte chemotactic protein)
and mortality (Kidd et al., 2008). In this model, pharmacolog-
ical or genetic inhibition of the PI3K–Akt pathway suppresses
insulin’s anti-inﬂammatory actions (Zhang et al., 2007b; Kidd
et al., 2008; Luyendyk et al., 2008). Recent studies support a role
for hypothalamic inﬂammation and the resultant insulin and lep-
tin resistance as triggering factors of hyperphagia and obesity
(Thaler and Schwartz, 2010). Future studies should investigate if
chronic levels of pro-inﬂammatory cytokines in the brain affect
PI3K signaling in hypothalamic centers involved in the control
of both reproduction and metabolism such as the ARC. This
could reveal a possible mechanism by which insulin sensitizers
such as metformin restore normal gonadotropin levels in PCOS
patients.
FIGURE 2 | States of metabolic imbalance such as malnutrition and
obesity have detrimental effects on the HPG axis, principally altering
normal GnRH pulsatile release. Alterations in the levels and sensitivity to
peripheral hormones and metabolic signals, including IGF-1, E2, leptin, and
insulin, play a major role in the dysfunction of the HPG axis during chronic
metabolic disturbances. PI3K is a major signaling pathway activated by the
same upstream regulators that are affected during such states. In rodents,
PI3K participates in the central control of sexual behavior and LH release. In
this model altered PI3K signaling is linked to the negative effects that
metabolic imbalance has on the HPG axis.
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SUMMARY AND CONCLUSION
Central dysregulation of GnRH neurosecretion underlies the
reproductive dysfunction observed during states of metabolic
imbalance, such as malnutrition and chronic nutritional excess.
The inability of peripheral hormones and metabolic cues to reg-
ulate key hypothalamic centers plays a major role in the negative
effects that these states have on the HPG axis. Hormones and
growth factors key for the central control of GnRHrelease,puberty,
and sexual behavior utilize the PI3K signaling pathway to reg-
ulate a variety of physiological functions including metabolism.
Examples include insulin, leptin, IGF-1, and E2, whose levels and
capacity to act in the brain is severely compromised during con-
ditions of disturbed energy homeostasis (Figure 2). In rodents,
PI3K participates in the central control of female sexual behav-
ior (Etgen and Acosta-Martinez, 2003) and gonadotropin release
(Acosta-Martinez et al., 2009). A direct link between impaired
PI3K signaling and the detrimental effects that a disturbed energy
homeostasis has on the HPG axis has not been established. How-
ever, PI3K plays a central role mediating the effects of insulin
and leptin on feeding and metabolism. Moreover, these meta-
bolic signals also utilized PI3K to regulate the neuronal activity
and expression of neuropeptide systems that are important reg-
ulators of GnRH release, such as NPY and POMC. To test the
hypothesis that PI3K signaling represents a link between metabo-
lism and reproduction, experimental approaches similar to those
used to investigate its role in the central control of metabolism
should be used. For example, the use of the Cre/LoxP system to
alter PI3K gene expression in neuronal populations critical for
the control of gonadotropin release, such as kisspeptin, will con-
tinue to shed light into the role of this enzyme in the control of
reproduction. Similarly, adenoviral gene therapy could be used to
investigate if the detrimental effects of negative energy balance
and obesity on LH release is prevented or restored by activation
of PI3K signaling in speciﬁc brain regions, like the POA and the
ARC.
Finally, chronic inﬂammation has been identiﬁed recently as
an important component of the pathophysiology of obesity and
the metabolic syndrome. These and other metabolic conditions
have a major impact on fertility. Therefore, it is important to iden-
tify the intracellular mechanisms that are at play during chronic
inﬂammation within the CNS. Because a direct consequence of
inﬂammation is central insulin and leptin resistance, signaling
pathways shared by these hormones, such as PI3K, should be
investigated.
The use of pharmacological agents that target different classes
of PI3K is already being considered as a therapeutic strategy to
treat cancer and metabolic diseases (Holmes, 2011). The insights
described within this review highlight the need to also address
PI3K and its role in the central control of reproduction. Disor-
ders that span both metabolic and reproductive function, such
as PCOS, may have some potential for PI3K pharmacological
targeting.
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